NRG2025 Winter NRG Web Hero(2).png

NRG2025 Winter Meeting

Registration is Now Open!  Join us in Phoenix, AZ f or the NRG2025 Winter Meeting. The meeting will be held in-person, January 16-18, 2025, with select virtual sessions being held January 6-14, 2025. Register soon to avoid the late registration fee! Visit the NRG2025 page for details!

A Focus On Science

NRG Oncology and its partners have more than 150 years experience in conducting practice-defining, multi-institutional phase II and III trials sponsored primarily by the National Cancer Institute (NCI), as well as a history of undertaking the kind of phase I trials and translational biological studies that will be imperative for future clinical cancer research.

 

>
NCI Community Oncology Research Programs NCI National Clinical Trials Program

Uniquely positioned

Internationally recognized investigators populate the leadership and membership of all seven cancer disease site committees encompassed by NRG Oncology.

  • Brain tumors
  • Breast cancer
  • Gastrointestinal cancer
  • Genitourinary cancer
  • Gynecologic cancer
  • Head and Neck cancer
  • Lung cancer
Learn More For Patients
NRG is a platform to find better treatment for cancer of tomorrow.

Ending Cancer

Ending cancer as we know it means commitment to research. Commitment for funding, commitment to participate, and commitment from researchers. Working together makes a difference. Cynthia Licavoli, RN

Ending Cancer

Our Mission

Improve the lives of patients with cancer by conducting practice-changing multi-institutional clinical and translational research

Dr. Robert S. Mannel

Our exceptional network brings individuals together who are passionate about changing the future of cancer care through impactful clinical trials.

Membership Resources

NRG Oncology's membership roster is comprised of over 1,000 member sites including institutions on five continents. Our investigators represent all of the oncologic medical specialties and disciplines.

Learn More

Latest News

Card image cap
NRG Oncology Study Suggests the Addition of SBRT to Systemic Therapy Improves Outcomes for Select Patients with Locally Advanced Hepatocellular Carcinoma

Read More
Card image cap
FORTE Study Update: December 2024 Newsletter

Read More
Card image cap
PSC Continuing Education Sessions at #NRG2025

Read More

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are one of the leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy